Bromodomain, Testis-Specific (BRDT) (N-Term) Peptide
BRDT
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all BRDT products
- BRDT (Bromodomain, Testis-Specific (BRDT))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- MSLPSRQTAI IVNPPPPEYI NTKKNGRLTN QLQYLQKVVL KDLWKHSFSW
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-BRDT Antibody,. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BRDT (Bromodomain, Testis-Specific (BRDT))
- Background
-
BRDT is similar to the RING3 protein family. It possesses 2 bromodomain motifs and a PEST sequence (a cluster of proline, glutamic acid, serine, and threonine residues), characteristic of proteins that undergo rapid intracellular degradation. The bromodomain is found in proteins that regulate transcription. Two transcript variants encoding the same protein have been found for this gene.
Alias Symbols: BRD6, CT9
Protein Interaction Partner: HIST2H4A
Protein Size: 947 - Molecular Weight
- 108 kDa
- Gene ID
- 676
- NCBI Accession
- NM_001726, NP_001717
- UniProt
- Q58F21
-
You are here:
